- Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the rat. Stemp, G., Ashmeade, T., Branch, C.L., Hadley, M.S., Hunter, A.J., Johnson, C.N., Nash, D.J., Thewlis, K.M., Vong, A.K., Austin, N.E., Jeffrey, P., Avenell, K.Y., Boyfield, I., Hagan, J.J., Middlemiss, D.N., Reavill, C., Riley, G.J., Routledge, C., Wood, M. J. Med. Chem. (2000)